203 related articles for article (PubMed ID: 37688712)
21. Clinical Outcomes of Start-Low, Go-Slow Methadone Initiation for Cancer-Related Pain: What's the Hurry?
Hawley P; Chow L; Fyles G; Shokoohi A; O'Leary MJ; Mittelstadt M
J Palliat Med; 2017 Nov; 20(11):1244-1251. PubMed ID: 28595027
[TBL] [Abstract][Full Text] [Related]
22. Rotation to methadone after opioid dose escalation: How should individualization of dosing occur?
Zimmermann C; Seccareccia D; Booth CM; Cottrell W
J Pain Palliat Care Pharmacother; 2005; 19(2):25-31. PubMed ID: 16061458
[TBL] [Abstract][Full Text] [Related]
23. Methadone for Pain Management in Children with Cancer.
Habashy C; Springer E; Hall EA; Anghelescu DL
Paediatr Drugs; 2018 Oct; 20(5):409-416. PubMed ID: 30047027
[TBL] [Abstract][Full Text] [Related]
24. Methadone rotation versus other opioid rotation for refractory cancer induced bone pain: protocol of an exploratory randomised controlled open-label study.
Michael N; Sulistio M; Wojnar R; Gorelik A
BMC Palliat Care; 2023 Apr; 22(1):42. PubMed ID: 37059995
[TBL] [Abstract][Full Text] [Related]
25. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit.
Mercadante S; Ferrera P; Villari P; Casuccio A; Intravaia G; Mangione S
J Pain Symptom Manage; 2009 Apr; 37(4):632-41. PubMed ID: 19345298
[TBL] [Abstract][Full Text] [Related]
26. Methadone and Corrected QT Prolongation in Pain and Palliative Care Patients: A Case-Control Study.
Juba KM; Khadem TM; Hutchinson DJ; Brown JE
J Palliat Med; 2017 Jul; 20(7):722-728. PubMed ID: 28186837
[TBL] [Abstract][Full Text] [Related]
27. The role of methadone in cancer-induced bone pain: a retrospective cohort study.
Sulistio M; Wojnar R; Key S; Kwok J; Al-Rubaie Z; Michael N
Support Care Cancer; 2021 Mar; 29(3):1327-1335. PubMed ID: 32627056
[TBL] [Abstract][Full Text] [Related]
28. A Case of Opioid-Induced Hyperalgesia.
Wall J; Chauhan A
J Pain Palliat Care Pharmacother; 2018; 32(2-3):158-160. PubMed ID: 30592628
[TBL] [Abstract][Full Text] [Related]
29. Methadone prescribed as an analgesic by a specialist palliative medicine team in an acute hospital inpatient setting: retrospective study.
Hayes J; Waldron D; Levins KJ; Gaffney L; Azhar M; Beatty S; Mannion E
BMJ Support Palliat Care; 2024 Jan; 13(e3):e839-e842. PubMed ID: 36104162
[TBL] [Abstract][Full Text] [Related]
30. Switching from oxycodone to methadone in advanced cancer patients.
Mercadante S; Ferrera P; Villari P; Adile C; Casuccio A
Support Care Cancer; 2012 Jan; 20(1):191-4. PubMed ID: 21901297
[TBL] [Abstract][Full Text] [Related]
31. Opioids in Cancer Pain: Right or Privilege?
Jackson LK; Imam SN; Braun UK
J Oncol Pract; 2017 Sep; 13(9):e809-e814. PubMed ID: 28557661
[TBL] [Abstract][Full Text] [Related]
32. Methadone initiation and rotation in the outpatient setting for patients with cancer pain.
Parsons HA; de la Cruz M; El Osta B; Li Z; Calderon B; Palmer JL; Bruera E
Cancer; 2010 Jan; 116(2):520-8. PubMed ID: 19924788
[TBL] [Abstract][Full Text] [Related]
33. An overview of the current drug treatment strategies for moderate to severe, chronic malignant tumor-related pain.
Mercadante S
Expert Opin Pharmacother; 2024 Feb; 25(2):171-179. PubMed ID: 37016731
[TBL] [Abstract][Full Text] [Related]
34. Switching methadone: a 10-year experience of 345 patients in an acute palliative care unit.
Mercadante S
Pain Med; 2012 Mar; 13(3):399-404. PubMed ID: 22360828
[TBL] [Abstract][Full Text] [Related]
35. Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors.
Benítez-Rosario MA; Salinas-Martín A; Aguirre-Jaime A; Pérez-Méndez L; Feria M
J Pain Symptom Manage; 2009 Jun; 37(6):1061-8. PubMed ID: 19171458
[TBL] [Abstract][Full Text] [Related]
36. Myoclonus associated with high-dose parenteral methadone.
Ito S; Liao S
J Palliat Med; 2008 Jul; 11(6):838-41. PubMed ID: 18715174
[TBL] [Abstract][Full Text] [Related]
37. Methadone as the Initial Long-Acting Opioid in Children with Advanced Cancer.
Madden K; Mills S; Dibaj S; Williams JL; Liu D; Bruera E
J Palliat Med; 2018 Sep; 21(9):1317-1321. PubMed ID: 29664690
[TBL] [Abstract][Full Text] [Related]
38. Conversion ratios for opioid switching: a pragmatic study.
Mercadante S; Adile C; Ferrera P; Grassi Y; Cascio AL; Casuccio A
Support Care Cancer; 2022 Dec; 31(1):91. PubMed ID: 36580152
[TBL] [Abstract][Full Text] [Related]
39. Opioid plasma concentrations during a switch from transdermal fentanyl to methadone.
Mercadante S; Villari P; Ferrera P; Casuccio A; Gambaro V
J Palliat Med; 2007 Apr; 10(2):338-44. PubMed ID: 17472504
[TBL] [Abstract][Full Text] [Related]
40. The frequency of QTc prolongation among pediatric and young adult patients receiving methadone for cancer pain.
Madden K; Park M; Liu D; Bruera E
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28449209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
